Authors: Madoiwa, S Nakamura, Y Mimuro, J Furusawa, S Koyama, T Sugo, T Matsuda, M Sakata, Y

Citation: S. Madoiwa et al., Autoantibody against prothrombin aberrantly alters the proenzyme to facilitate formation of a complex with its physiological inhibitor antithrombin III without thrombin conversion, BLOOD, 97(12), 2001, pp. 3783-3789

Authors: Sugo, T Nakamikawa, C Yoshida, N Niwa, K Sameshima, M Mimuro, J Weisel, JW Nagita, A Matsuda, M

Citation: T. Sugo et al., End-linked homodimers in fibrinogen Osaka VI with a B beta-chain extensionlead to fragile clot structure, BLOOD, 96(12), 2000, pp. 3779-3785

Authors: Mimuro, J Kawata, Y Niwa, K Muramatsu, S Madoiwa, S Takano, H Sugo, T Sakata, Y Sugimoto, T Nose, K Matsuda, M

Citation: J. Mimuro et al., A new type of Ser substitution for gamma arg-275 in fibrinogen Kamogawa I characterized by impaired fibrin assembly, THROMB HAEM, 81(6), 1999, pp. 940-944

Authors: Madoiwa, S Komatsu, N Mimuro, J Kimura, K Matsuda, M Sakata, Y

Citation: S. Madoiwa et al., Developmental expression of plasminogen activator inhibitor-1 associated with thrombopoietin-dependent megakaryocytic differentiation, BLOOD, 94(2), 1999, pp. 475-482

Authors: Sugo, T Nakamikawa, C Takano, H Mimuro, J Yamaguchi, S Mosesson, MW Meh, DA DiOrio, JP Takahashi, N Takahashi, H Nagai, K Matsuda, M

Citation: T. Sugo et al., Fibrinogen Niigata with impaired fibrin assembly: An inherited dysfibrinogen with a B beta Asn-160 to Ser substitution associated with extra glycosylation at B beta Asn-158, BLOOD, 94(11), 1999, pp. 3806-3813